Back to LMR Partners LLP LMR Partners LLP

RLMDRLMD
5 quarters

Position history for LMR Partners LLPLMR Partners LLP's holdings in RELMADA THERAPEUTICS INC

Yes. LMR Partners holds 55,600 shares of RLMD (Relmada Therapeutics), worth $384,752, as of its Q2 2026 13F filing. It reduced the position by 7,984 shares (-12.6%) from Q1 2026. LMR Partners has held RLMD since Q2 2025, across 5 quarterly 13F filings.

Current Value

$384,752

Current Shares

55,600

Total Value Change

+$351,673

Total Shares Change

+496

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
55,600
-12.6%
$384,7520.0%$6.92
0
2026-Q1
Increased
63,584
+14.4%
$442,5450.0%$4.67
27
2025-Q4
Unchanged
55,600
0.0%
$268,5480.0%$4.53
0
2025-Q3
Increased
55,600
+0.9%
$111,7560.0%$1.88
22
2025-Q2
New
55,104
-
$33,0790.0%$0.61
27

Other major holders of RLMD: RTW INVESTMENTS, LP, Jupiter Topco LLC, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used